Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck

Samantha Tam; Christopher M. K. L. Yao; Moran Amit; Mona Gajera; Xiaoning Luo; Rachel Treistman; Anshu Khanna; Mohamed Aashiq; Priyadharsini Nagarajan; Diana Bell; Adel K. El‐Naggar; Michael R. Migden; Michael K. Wong; Bonnie S. Glisson; Renata Ferrarotto; Bita Esmaeli; David I. Rosenthal; Guojun Li; Randal S. Weber; Jeffrey N. Myers; Neil D. Gross

doi:10.1001/jamaoto.2019.3751

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

This study's findings suggest that immunosuppression is independently associated with a worse outcome in cSCC, with a 2.32 times increased risk of disease-specific death after adjusting for age, history of skin cancer, recurrent or persistent disease status, disease stage, and treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tam et al. (2019) studied this question.

synapsesocial.com/papers/69d88908c025a7c015bedfb1 https://doi.org/10.1001/jamaoto.2019.3751

View Full Paper

Ask AI

Bookmark

Share

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck

Ask about this paper

Abstract

Discussion

Cite This Study

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading